GAO says US FDA must do more to ensure accuracy of antibiotic labels
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has failed to take the necessary steps to ensure that the labels of marketed antibiotics are kept sufficiently up to date to help clinicians determine the best antibiotic to treat a particular bacterial infection, reveals a Government Accountability Office report1.